Introduction: Hengrun Shengda is a research and development company of tumor immunotherapy technology. It uses CAR-T, a tumor immunotherapy technology, to provide precise treatment programs based on biological and cellular technologies for tumor patients, and has built central clinical trial platforms in Beijing, Jiangsu, Chongqing, Henan and other places.
Legal Representative: Li Guoshun.
Establishment time: 20 15-07-20
Registered capital: 664819.95 million yuan.
Industrial and commercial registration number: 31014100177980.
Enterprise type: limited liability company (natural person investment or holding)
Company address: Room 6 1 1 of China Cai Lunlu (Shanghai) Pilot Free Trade Zone.